Citadel Advisors
NUVL icon

Citadel Advisors’s Nuvalent NUVL Stock Holding History

Citadel Advisors’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.1M Sell
166,773
-28,383
-15% -$2.89M ﹤0.01% 2521
2025
Q4 		$19.6M Buy
195,156
+164,930
+546% +$16.3M ﹤0.01% 2369
2025
Q3 		$2.61M Sell
30,226
-33,614
-53% -$2.66M ﹤0.01% 5554
2025
Q2 		$4.87M Buy
63,840
+26,440
+71% +$1.93M ﹤0.01% 4157
2025
Q1 		$2.65M Sell
37,400
-72,695
-66% -$5.68M ﹤0.01% 4991
2024
Q4 		$8.62M Sell
110,095
-132,463
-55% -$12.4M ﹤0.01% 3175
2024
Q3 		$24.8M Buy
242,558
+236,774
+4,094% +$19.6M ﹤0.01% 1831
2024
Q2 		$439K Sell
5,784
-104,100
-95% -$7.4M ﹤0.01% 8319
2024
Q1 		$8.25M Sell
109,884
-99,257
-47% -$7.9M ﹤0.01% 3180
2023
Q4 		$15.4M Buy
209,141
+208,934
+100,934% +$12.9M ﹤0.01% 2301
2023
Q3 		$9.52K Sell
207
-44,963
-100% -$2M ﹤0.01% 13121
2023
Q2 		$1.9M Buy
45,170
+19,526
+76% +$738K ﹤0.01% 5231
2023
Q1 		$669K Buy
25,644
+25,410
+10,859% +$751K ﹤0.01% 7683
2022
Q4 		$6.97K Sell
234
-40,231
-99% -$1.12M ﹤0.01% 13866
2022
Q3 		$787K Sell
40,465
-52,297
-56% -$875K ﹤0.01% 7506
2022
Q2 		$1.26M Buy
92,762
+45,299
+95% +$479K ﹤0.01% 6501
2022
Q1 		$660K Buy
+47,463
New +$689K ﹤0.01% 8717

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors's NUVL Position: Q1 2026 in Review

Citadel Advisors reduced its Nuvalent (NUVL) stake by 15% in Q1 2026, selling an estimated $2.89M and leaving 166,773 shares worth $17.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2521.

Citadel Advisors first reported a position in NUVL in Q1 2022 and has held it in 17 quarters since. The position peaked at $24.8M in Q3 2024. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Citadel Advisors held 166,773 shares of Nuvalent worth $17.1M as of Q1 2026.
  • Citadel Advisors sold 28,383 Nuvalent shares in Q1 2026, an estimated $2.89M.
  • Nuvalent made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2521 holding.
  • Citadel Advisors first reported a position in Nuvalent in Q1 2022 and has held it in 17 quarters since.
  • Citadel Advisors's Nuvalent position peaked at $24.8M in Q3 2024.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.